From: Safety of an extended-release injectable moxidectin suspension formulation (ProHeart® 12) in dogs
Study day | Control (n = 8) | 1.50 mg/kg moxidectin (n = 7) | % Reductiona |
---|---|---|---|
Day -70 | 0 | 0 | |
Day -49 | 6.4 | 4.8 | |
Day -35 | 55.5 | 113.8 | |
Day -21 | 730.6 | 1743.4 | |
Day -7 | 3401.1 | 4855.3 | |
Day -2 | 2648.3 | 2446.4 | |
Day 1 | 4228.8 | 5622.0 | 0 |
Day 4 | 4393.4 | 693.1 | 84.22 |
Day 8 | 4828.5 | 57.4 | 98.81 |
Day 15 | 6271.6 | 5.6 | 99.91 |
Day 22 | 9269.0 | 4.6 | 99.95 |
Day 29 | 7413.1 | 2.5 | 99.97 |
Day 43 | 5186.0 | 4.2 | 99.92 |